News from acelrx pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 02, 2014, 07:00 ET
AcelRx logo

AcelRx Pharmaceuticals Receives CE Mark Approval for Zalviso

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Nov 20, 2014, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals to Participate in Four Upcoming Investor Events

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Nov 13, 2014, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals Announces Zalviso™ Sublingual Sufentanil Data Presentation At The American Society Of Regional Anesthesia And Pain Medicine Meeting

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Nov 10, 2014, 16:01 ET
AcelRx logo.

AcelRx Pharmaceuticals Reports Third Quarter 2014 Financial Results

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Nov 10, 2014, 07:00 ET

AcelRx Pharmaceuticals Receives International Standards Organization (ISO) 13485:2003 Certification of its Quality Management System

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Nov 07, 2014, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Nov 06, 2014, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals to Hold Third Quarter Financial Results Conference Call and Webcast on Monday, November 10, 2014

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of...

Nov 05, 2014, 16:00 ET
AcelRx logo

Acelrx Pharmaceuticals Announces Management Change

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Oct 27, 2014, 07:00 ET
AcelRx logo

AcelRx Pharmaceuticals Announces Sublingual Sufentanil Data Presentations At The American College Of Surgeons Meeting

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) today announced that multiple moderated poster presentations will be made at the American College of...

Oct 22, 2014, 07:00 ET
AcelRx logo.

AcelRx Announces Publication of Zalviso Phase 3 Abdominal Trial Results

 AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) today announced that results from the  IAP310 study have been published in Regional...

Oct 16, 2014, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals Provides Update on its Patent Portfolio for Zalviso™ and its Proprietary Platform Technologies

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Oct 10, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals Announces Multiple Sublingual Sufentanil Data Presentations At The American Society Of Anesthesiologists Meeting

 AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) today announced that multiple moderated poster presentations will be made at the upcoming American...

Oct 06, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

Sufentanil sublingual tablet system study results to be presented at the International Association for the Study of Pain Meeting

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Sep 26, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals Provides Regulatory Update on Zalviso™

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of...

Sep 10, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Announces Publication of Manuscript Analyzing Cost of Intravenous Patient-Controlled Analgesia with Opioids

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Sep 04, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Announces Publication of Sufentanil Sublingual Tablet System vs. Intravenous Patient-Controlled Analgesia with Morphine for Postoperative Pain Study Results

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Aug 27, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Aug 11, 2014, 16:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals Reports Second Quarter 2014 Financial Results

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Aug 08, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals to Participate in Three Upcoming Investor Events

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Aug 07, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals to Hold Second Quarter Financial Results Conference Call and Webcast on Monday, August 11th, 2014.

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...